New Book on Early Breast Cancer Released at ISMPO Congress: A Comprehensive, Evidence-Based Guide for Clinicians
The Indian Society of Medical and Pediatric Oncology (ISMPO) Congress which was recently held in Jaipur saw the launch of a major new resource, Early Breast Cancer: Evidence-Based Diagnosis and Treatment, providing a comprehensive, multidisciplinary guide to managing early-stage breast cancer.
Edited by Dr. Hemant Malhotra and published by Springer Nature India Private Limited, this book offers a globally relevant yet India-focused approach, consolidating current evidence, evolving treatment strategies, and practical clinical guidance.
The book is split into 14 chapters and is contributed by 23 eminent medical experts and oncologists.
The book begins with a detailed overview of breast cancer epidemiology and trends by Dr. Indoo Ammbulkar, who discusses the rising incidence of breast cancer globally and in India. The screening guidelines and recommendations chapter by Dr. Jaishree Goyal provides a thorough analysis of both global and Indian screening protocols.
Further chapters by Dr. Roshni Bhagwat Pande highlights AI’s role in improving breast cancer screening, enhancing mammography and MRI accuracy, and enabling earlier detection of lesions. While Dr. Archit Joshi, Dr. Hemanth Kumar, and Dr. L.P. Bhaskar Bhuvan discuss the paradigm shift from radical mastectomy to breast-conserving surgery and sentinel lymph node biopsy, with an in-depth look at neoadjuvant therapies in early breast cancer.
Dr. Adhip Arora, Dr. Mounika Pallati, and Dr. Atul Batra provide an extensive overview of chemotherapy, endocrine therapy, targeted therapies, and immunotherapy for early-stage breast cancer.
Dr. Ajay Yadav, Dr. Hemant Malhotra, and Dr. Chhavi Goyal, mention about the impact of these therapies on hormone receptor-positive breast cancer. Dr. Nitin Khunteta covers the importance of sentinel lymph node biopsy (SLNB) in assessing axillary nodal involvement.
Following chapter by Dr. Aniket Goenka highlights the management of breast cancer in special populations, including elderly patients, men with breast cancer, and pregnancy-associated breast cancer. Dr. Raja Pramanik explores genetics and hereditary factors and the role of multigene panel testing in identifying individuals at high risk and personalizing treatment plans.
Psychological support and nutritional guidance are also key areas covered, with contributions from Dr. Arati Hota and Dr. Vineeta Bansal, who emphasize the holistic care approach necessary for cancer patients throughout their treatment journey.
Other contributions, including Dr. TVSVGK Tilak focuses on the long-term effects of cancer treatments and provides essential strategies for managing the health and quality of life of breast cancer survivors.
Subsequently, Dr. Satyajit Soni and Dr. Arpit Jain cover targeted therapy and future directions in early breast cancer treatment, as well as the importance of supportive care and survivorship planning.
Dr. Geeta Kadayaprath, Dr. Preeti Grewal, and Dr. Shreya Chopra provide practical guidance on the evolution of breast cancer surgery, including the role of new techniques and technologies in improving surgical outcomes.
Scan the QR Code or Click on the link below to access the book.
Reference: Early Breast Cancer: Evidence-Based Diagnosis and Treatment, Springer Nature India Private Limited
PP-AL-IN-1854 | 19/12/2025
Eli Lilly and Company (India) Private Limited
For further Information about Lilly and Lilly products please contact us at the below address: Plot 92, Sector 32 Gurgaon, Haryana, 122001, India Ph.: +91-124-4753000/01 | www.lilly.com/in
For adverse events and safety reporting, please reach out to: mailbox_in-gps@lilly.com | For any additional information related to Lilly products, please reach out to: queries_in-medinfo@lilly.com.
This material (including any link) is intended solely for the use of the recipient(s) and may contain confidential information. Any unauthorized review, use, disclosure, copying, or distribution is strictly prohibited. If you are not the intended recipient, please notify the sender immediately and destroy all copies of the material. The information provided in this section is intended solely for the use of registered medical practitioner. This material is being provided to healthcare professionals only for their guidance and use. Nothing on this website/microsite/material should be construed as giving medical advice or making recommendations regarding any health-related decision or action.
© 2025 Eli Lilly and Company
